Advertisement

Topics

Stoke Therapeutics, Inc Company Profile

19:05 EDT 24th April 2018 | BioPortfolio

Stoke Therapeutics is a biotechnology company working to increase gene expression to treat a wide array of severe genetic diseases, including genetic conditions affecting the central nervous system, eye, and liver. Stoke was launched in 2018 with a $40 million Series A investment funded by Apple Tree Partners. For more information visit www.stoketherapeutics.com


News Articles [730 Associated News Articles listed on BioPortfolio]

Stoke Therapeutics closes $40mm Series A

Stoke Therapeutics Inc. (therapies for genetic disorders) raised $40mm in its Series A financing from founding investor Apple Tree Partners.

Stoke Therapeutics Presents Early Research on its Novel ASO Pipeline for Severe Genetic Diseases at OPT Boston

Stoke Therapeutics, Inc., a biotechnology company developing therapeutics that increase gene expression to treat a wide array of diseases caused by genetic insufficiency, will pre...

Royal Stoke consultant apologises for ‘third world’ conditions in hospital’s A&E – Stoke Sentinel

Stoke SentinelRoyal Stoke consultant apologises for 'third world' conditions in hospital's A&EStoke SentinelEnter your postcode to see news and information near you Community updates, Crime Statis...

Stoke Med to Provide Patient Specific 3D-Printed Models

RALEIGH, N.C., Feb. 20, 2018/PRNewswire/ -- Stoke Ventures, a company leading the way in product launch services is excited to announce their latest venture, Read more...

Stoke Therapeutics Comes Out of Seed Mode With $40M and Ex-Sarepta CEO at Its Helm

The Series A round was provided by founding investor Apple Tree Partners.

NHS SOS: Campaigners: ‘Bed closures have put patients at risk’ – Stoke-on-Trent Live

Stoke-on-Trent LiveNHS SOS: Campaigners: 'Bed closures have put patients at risk'Stoke-on-Trent LiveCampaigners fighting to save community hospital beds across North Staffordshire say closures have pu...

Stoke Therapeutics Expands Leadership Team, Building on Deep Expertise in Oligonucleotide Chemistry and Rare Disease Research and Development

Stoke Therapeutics, Inc., a biotechnology company developing therapeutics that increase gene expression to treat a wide array of diseases caused by genetic insufficiency, t...

Health Secretary Jeremy Hunt hails pay deal – Stoke-on-Trent Live

Stoke-on-Trent LiveHealth Secretary Jeremy Hunt hails pay dealStoke-on-Trent LiveUnison members are currently voting on whether to accept a pay deal which has promised to give staff wage rises of betw...

PubMed Articles [416 Associated PubMed Articles listed on BioPortfolio]

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Eyes on New Product Development: Preclinical Research.

Introduction to Volume 2 of JOPT Special Issue.

Introduction to Volume 1 of JOPT Special Issue.

Clinical Trials [157 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1218 Associated Companies listed on BioPortfolio]

Stoke Therapeutics, Inc.

Stoke Therapeutics is a biotechnology company working to increase gene expression to treat a wide array of severe genetic diseases, including genetic conditions affecting the cent...

Stoke Therapeutics, Inc

Stoke Therapeutics is a biotechnology company working to increase gene expression to treat a wide array of severe genetic diseases, including genetic conditions affecting the cent...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Stoke Therapeutics, Inc" on BioPortfolio

We have published hundreds of Stoke Therapeutics, Inc news stories on BioPortfolio along with dozens of Stoke Therapeutics, Inc Clinical Trials and PubMed Articles about Stoke Therapeutics, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Stoke Therapeutics, Inc Companies in our database. You can also find out about relevant Stoke Therapeutics, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...


Corporate Database Quicklinks



Searches Linking to this Company Record